Chubb Ltd
CB
Visa
V
MasterCard
MA
Bank of America
BAC
The Kroger
KR
US Stock MarketDetailed Quotes
CALA Calithera Biosciences
- 0.000600
- 0.0000000.00%
15min DelayTrading Feb 6 16:00 ET
2.92KMarket Cap0.00P/E (TTM)
0.000000High0.000000Low1Volume0.005000Open0.000600Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)4.87MShares0.12000052wk High0.00P/B2.89KFloat Cap0.00010052wk Low--Dividend TTM4.82MShs Float669.600000Historical High--Div YieldTTM0.00%Amplitude0.000100Historical Low0.000000Avg Price1Lot Size
Calithera Biosciences Key Stats
EPS
According to the latest financial report of Calithera Biosciences, the latest earnings per share (TTM) for the company is -1.45. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Calithera Biosciences's free cash flow? The latest report shows it as -8.62M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Calithera Biosciences shows that the company's current ratio is 3.60, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Calithera Biosciences, the quick ratio is 3.44, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Calithera Biosciences? The latest ROE figure is -661.83%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Calithera Biosciences, the total asset return on investment (ROA) is -21.10%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Calithera Biosciences's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Calithera Biosciences, the net profit margin is -165.51%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.